Kyle McMahon
Research Associate specializing in viral diagnostics and molecular surveillance
Boston, Massachusetts
Summary
Kyle McMahon is a dedicated Research Associate at the Broad Institute of MIT and Harvard, specializing in viral diagnostics and molecular surveillance. His work, particularly within the Sabeti Lab, focuses on developing and optimizing advanced PCR-based detection assays and sequencing protocols for critical public health threats like the H5N1 influenza virus. google+3
His expertise extends to developing and adapting high-throughput diagnostic tools, including the CRISPR-Cas13 CARMEN RVP assay, for environmental monitoring of respiratory pathogens. This includes work on analyzing air samples to track viruses like SARS-CoV-2 and influenza A in congregate settings, highlighting his commitment to innovative public health surveillance. google+1
Beyond his scientific research, Kyle has a background in public service, having served as a Rural Aquaculture Promotion Agent with the Peace Corps. He also contributes to global initiatives as a reviewer for The World Food Prize Foundation, demonstrating a broader interest in addressing worldwide challenges. dnb
Work
Education
Writing
Establishing Methods to Monitor Influenza (A)H5N1 Virus in Dairy Cattle Milk, Massachusetts, USA
January 1, 2025Developed and optimized PCR-based detection assays and sequencing protocols to support H5N1 molecular surveillance in dairy cattle milk, revealing non-infectious H5N1 RNA in retail milk samples.
Adaptation of the multiplexed CRISPR-Cas13 CARMEN RVP assay for longitudinal detection of respiratory pathogens from air samples
January 1, 2025Modified and optimized the CARMEN RVP assay for air surveillance to detect respiratory pathogens like SARS-CoV-2 and influenza A in air samples from schools, demonstrating its utility for environmental surveillance.
Multiplexed detection of febrile infections using CARMEN
January 1, 2024Contributed to research on multiplexed detection methods for febrile infections using the CARMEN platform.